Drug Type Small molecule drug |
Synonyms- |
Target |
Action stimulants |
Mechanism LANCL2 stimulants(LanC like 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Lupus Vulgaris | Preclinical | - | - | |
| Rheumatoid Arthritis | Discovery | United States | 26 Oct 2021 | |
| Systemic Lupus Erythematosus | Discovery | United States | 25 Oct 2021 | |
| Lupus Nephritis | Discovery | United States | 11 Nov 2019 |





